美国不同种族和族裔群体中精神病性障碍发病率的不平等
该回顾性队列研究分析了2009至2019年Kaiser Permanente Northern California的5,994,758名成员,发现非情感性精神病性障碍总体发病率略有下降,但黑人(HR=2.13)和美洲印第安人或阿拉斯加原住民(HR=1.85)风险高于白人,亚裔(HR=0.72)和西班牙裔(HR=0.91)风险较低;精神病性障碍与自杀、早逝和卒中风险升高及医疗服务利用降低相关。
要点
- 黑人及美洲印第安人/阿拉斯加原住民的非情感性精神病风险显著高于白人。
- 亚裔和西班牙裔的非情感性精神病风险低于白人。
- 精神病性障碍患者自杀(OR=2.65)、早逝(OR=1.30)和卒中(OR=1.64)风险更高,医疗服务利用更低(OR=0.44)。
核心结论
- 美国不同种族和族裔群体间精神病性障碍发病率存在差异,黑人及美洲印第安人/阿拉斯加原住民风险较高。
- 被诊断为精神病性障碍的个体承受更高的自杀、早逝和卒中风险,且医疗服务利用更低。
研究设计与样本
- 回顾性队列研究,纳入2009至2019年Kaiser Permanente Northern California的5,994,758名成员。
- 使用泊松回归评估年发病率变化,使用Cox比例风险模型和逻辑回归(校正年龄和性别)检验相关因素和结局。
主要发现
- 非情感性精神病性障碍总体发病率在研究期间略有下降。
- 相比白人,非情感性精神病诊断风险在黑人中较高(HR=2.13,95% CI=2.02-2.24),在美洲印第安人或阿拉斯加原住民中较高(HR=1.85,95% CI=1.53-2.23),在亚裔中较低(HR=0.72,95% CI=0.68-0.76),在西班牙裔中较低(HR=0.91,95% CI=0.87-0.96),在「其他」种族/族裔中较低(HR=0.92,95% CI=0.86-0.99)。
- 相比白人,校正年龄和性别后情感性精神病诊断风险在黑人中较高(HR=1.76,95% CI=1.62-1.91),在西班牙裔中较高(HR=1.09,95% CI=1.02-1.16),在美洲印第安人或阿拉斯加原住民中较高(HR=1.38,95% CI=1.00-1.90),在亚裔中较低(HR=0.77,95% CI=0.71-0.83),在夏威夷原住民或其他太平洋岛民中较低(HR=0.69,95% CI=0.48-0.99),在「其他」中较低(HR=0.86,95% CI=0.77-0.96)。
- 精神病性障碍与自杀(OR=2.65,95% CI=2.15-3.28)、早逝(OR=1.30,95% CI=1.22-1.39)和卒中(OR=1.64,95% CI=1.55-1.72)的更高几率相关,与医疗服务利用的更低几率相关(OR=0.44,95% CI=0.42-0.47)。
临床怎么用
- 临床应关注黑人及美洲印第安人/阿拉斯加原住民群体中较高的精神病性障碍风险,并考虑针对性筛查。
- 对精神病性障碍患者需监测自杀、早逝和卒中风险,并注意其医疗服务利用可能较低。
- 识别不同种族/族裔亚组中的风险和保护因素,有助于制定预防和干预策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The authors examined recent trends in incidence of psychotic disorders, demographic characteristics, and comorbid psychiatric and medical conditions among six racial/ethnic groups. METHOD: A retrospective cohort study design was used to examine the incidence of psychotic disorders across race/ethnicity groups and comorbid psychiatric and medical conditions among members of Kaiser Permanente Northern California from 2009 to 2019 (N=5,994,758). Poisson regression was used to assess changes in annual incidence, and Cox proportional hazards and logistic regression models adjusted for age and sex were used to test correlates and consequences. RESULTS: Overall, the incidence of nonaffective psychotic disorders decreased slightly over the study period. Compared with White members, the risk of nonaffective psychosis diagnosis was higher among Black (hazard ratio=2.13, 95% CI=2.02-2.24) and American Indian or Alaskan Native (AIAN) (hazard ratio=1.85, 95% CI=1.53-2.23) members and lower among Asian (hazard ratio=0.72, 95% CI=0.68-0.76) and Hispanic (hazard ratio=0.91, 95% CI=0.87-0.96) members, as well as those whose race/ethnicity was categorized as "other" (hazard ratio=0.92, 95% CI=0.86-0.99). Compared with White members, the risk of affective psychosis diagnosis adjusted for age and sex was higher among Black (hazard ratio=1.76, 95% CI=1.62-1.91), Hispanic (hazard ratio=1.09, 95% CI=1.02-1.16), and AIAN (hazard ratio=1.38, 95% CI=1.00-1.90) members and lower among Asian (hazard ratio=0.77, 95% CI=0.71-0.83), Native Hawaiian or other Pacific Islander (hazard ratio=0.69, 95% CI=0.48-0.99), and "other" (hazard ratio=0.86, 95% CI=0.77-0.96) members. Psychotic disorders were associated with significantly higher odds of suicide (odds ratio=2.65, 95% CI=2.15-3.28), premature death (odds ratio=1.30, 95% CI=1.22-1.39), and stroke (odds ratio=1.64, 95% CI=1.55-1.72) and lower odds of health care utilization (odds ratio=0.44, 95% CI=0.42-0.47). CONCLUSIONS: This study demonstrates racial and ethnic variation in incident psychotic disorder diagnoses in the United States, compared with non-Hispanic Whites. Individuals diagnosed with psychosis face a greater burden of other negative health outcomes and lower odds of health care utilization, reflecting personal and economic impacts. Identifying risk factors for elevated rates and protective influences in subgroups can inform strategies for prevention and interventions to ameliorate severe consequences of psychotic syndromes.
引用
- Chung W, Jiang SF, Milham MP, et al. Inequalities in the Incidence of Psychotic Disorders Among Racial and Ethnic Groups. Am J Psychiatry. 2023. PMID: 37789743. doi:10.1176/appi.ajp.20220917
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。